Sospensione degli UDCA nella PSC

Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis.Wunsch E, Trottier J, Milkiewicz M, Raszeja-Wyszomirska J, Hirschfield GM, Barbier O, Milkiewicz P. Hepatology. 2014 Sep;60(3):931-40 Ursodeoxycholic acid (UDCA) is no longer recommended for management of adult patients with primary sclerosing cholangitis (PSC). We undertook a prospective evaluation of UDCA withdrawal in a…